Figure 2.
Figure 2. Expression of PD-L1 and PD-1 on AML blasts and T cells prior to and during PEM therapy. PB- and BM-derived AML blasts (A-B) and T cells (C-F) were stained with fluorochrome-conjugated antibodies and analyzed by flow cytometry prior to and at various time points during PEM treatment. Blasts were defined as CD45low cells and stained for PD-L1 expression. Furthermore, T cells were characterized as CD45+, CD3+, and CD4+ or CD8+ populations. CD8+ T cells (C-D) and CD4+ T cells (E-F) were analyzed for their expression of PD-1 and PD-L1. Values in the graphs represent the percentage of cells staining positive for each molecule at indicated different time points.

Expression of PD-L1 and PD-1 on AML blasts and T cells prior to and during PEM therapy. PB- and BM-derived AML blasts (A-B) and T cells (C-F) were stained with fluorochrome-conjugated antibodies and analyzed by flow cytometry prior to and at various time points during PEM treatment. Blasts were defined as CD45low cells and stained for PD-L1 expression. Furthermore, T cells were characterized as CD45+, CD3+, and CD4+ or CD8+ populations. CD8+ T cells (C-D) and CD4+ T cells (E-F) were analyzed for their expression of PD-1 and PD-L1. Values in the graphs represent the percentage of cells staining positive for each molecule at indicated different time points.

Close Modal

or Create an Account

Close Modal
Close Modal